Virbac SA (VIRB)

368.00
+7.00(+1.94%)
  • Volume:
    1,883
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    361.00 - 369.50
  • Type:Equity
  • Market:France
  • ISIN:FR0000031577

VIRB Overview

Prev. Close
361
Day's Range
361-369.5
Revenue
1.06B
Open
362.5
52 wk Range
262.5-448.5
EPS
13.4
Volume
1,883
Market Cap
3.11B
Dividend (Yield)
1.25
(0.34%)
Average Vol. (3m)
6,797
P/E Ratio
27.47
Beta
0.77
1-Year Change
34.55%
Shares Outstanding
8,447,543
Next Earnings Date
Sep 15, 2022
What is your sentiment on Virbac?
or
Market is currently closed. Voting is open during market hours.

Virbac SA News

Virbac SA Company Profile

Virbac SA Company Profile

Employees
4907
Market
France

Virbac SA is a France-based veterinarian pharmaceutical company that specializes in the development and production of vaccines and medicines for domestic animals and livestock. Its production centers are located in France, Australia, the United States, Mexico, Vietnam, Brazil and South Africa. Its development efforts focus mainly on formulating drugs designed to prevent or cure certain animal diseases. Its product portfolio encompasses pet medications such as pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds and rodents, as well as livestock medications including pest control drugs and antibiotics intended for cattle, sheep, pigs and poultry. It also offers food and electronic identification chips for pets.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyBuyStrong BuyBuy
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy